Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.72EUR
−86.73 MEUR
27.40 M
About Mind Medicine (MindMed) Inc.
Sector
CEO
Robert Barrow
Headquarters
New York
Website
Employees (FY)
57
Founded
2019
FIGI
BBG00FD7MXZ1
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn in 2019 and is headquartered in New York, NY.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MMQ is 6.64 EUR — it has decreased by 1.12% in the past 24 hours. Watch MIND MEDICINE (MINDMED) INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange MIND MEDICINE (MINDMED) INC stocks are traded under the ticker MMQ.
MMQ stock has fallen by 3.49% compared to the previous week, the month change is a 12.64% fall, over the last year MIND MEDICINE (MINDMED) INC has showed a 120.58% increase.
We've gathered analysts' opinions on MIND MEDICINE (MINDMED) INC future price: according to them, MMQ price has a max estimate of 32.70 EUR and a min estimate of 14.95 EUR. Watch MMQ chart and read a more detailed MIND MEDICINE (MINDMED) INC stock forecast: see what analysts think of MIND MEDICINE (MINDMED) INC and suggest that you do with its stocks.
MMQ stock is 2.60% volatile and has beta coefficient of 1.83. Track MIND MEDICINE (MINDMED) INC stock price on the chart and check out the list of the most volatile stocks — is MIND MEDICINE (MINDMED) INC there?
Today MIND MEDICINE (MINDMED) INC has the market capitalization of 185.87 M, it has increased by 0.89% over the last week.
Yes, you can track MIND MEDICINE (MINDMED) INC financials in yearly and quarterly reports right on TradingView.
MIND MEDICINE (MINDMED) INC is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
MMQ earnings for the last quarter are −1.06 EUR per share, whereas the estimation was −0.49 EUR resulting in a −115.68% surprise. The estimated earnings for the next quarter are −0.31 EUR per share. See more details about MIND MEDICINE (MINDMED) INC earnings.
MIND MEDICINE (MINDMED) INC revenue for the last quarter amounts to 0 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
MMQ net income for the last quarter is −50.42 M EUR, while the quarter before that showed −21.62 M EUR of net income which accounts for −133.19% change. Track more MIND MEDICINE (MINDMED) INC financial stats to get the full picture.
No, MMQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 26, 2024, the company has 57.00 employees. See our rating of the largest employees — is MIND MEDICINE (MINDMED) INC on this list?
Like other stocks, MMQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MIND MEDICINE (MINDMED) INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MIND MEDICINE (MINDMED) INC technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MIND MEDICINE (MINDMED) INC stock shows the neutral signal. See more of MIND MEDICINE (MINDMED) INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.